SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter Heusler, Christiane Palmier, Stéphanie Tardif, Sophie Bernois, Francis C. Colpaert, Didier Cussac, [3H]-F13640, a novel, selective and high-efficacy serotonin 5-HT1A receptor agonist radioligand, Naunyn-Schmiedeberg's Archives of Pharmacology, 2010, 382, 4, 321

    CrossRef

  2. 2
    J. Robert Lane, Elisabeth Klaasse, Judy Lin, John van Bruchem, Margot W. Beukers, Adriaan P. IJzerman, Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor, Biochemical Pharmacology, 2010, 80, 8, 1180

    CrossRef

  3. 3
    Andria L. Del Tredici, Hans H. Schiffer, Ethan S. Burstein, Jelveh Lameh, Nina Mohell, Uli Hacksell, Mark R. Brann, David M. Weiner, Pharmacology of polymorphic variants of the human 5-HT1A receptor, Biochemical Pharmacology, 2004, 67, 3, 479

    CrossRef

  4. 4
    N Hanoun, F Saurini, L Lanfumey, M Hamon, S Bourgoin, Dihydroergotamine and its metabolite, 8′-hydroxy-dihydroergo-tamine, as 5-HT1A receptor agonists in the rat brain, British Journal of Pharmacology, 2003, 139, 2
  5. 5
    Adrian Newman-Tancredi, Laurence Verrièle, Mark J Millan, Differential modulation by GTPγS of agonist and inverse agonist binding to h5-HT1A receptors revealed by [3H]-WAY100,635, British Journal of Pharmacology, 2001, 132, 2
  6. 6
    Andrew J Montgomery, Christopher J Bench, Allan H Young, Alexander Hammers, Roger N Gunn, Zubin Bhagwagar, Paul M Grasby, PET measurement of the influence of corticosteroids on serotonin-1A receptor number, Biological Psychiatry, 2001, 50, 9, 668

    CrossRef

  7. 7
    Graeme Milligan, Elaine Kellett, Catherine Dacquet, Valérie Dubreuil, Edgar Jacoby, Mark J. Millan, Gilbert Lavielle, Michael Spedding, S 14506: novel receptor coupling at 5-HT1A receptors, Neuropharmacology, 2001, 40, 3, 334

    CrossRef

  8. 8
    David J. McLoughlin, Philip G. Strange, Mechanisms of Agonism and Inverse Agonism at Serotonin 5-HT1A Receptors, Journal of Neurochemistry, 2000, 74, 1
  9. 9
    Chiara Cappellini, Paolo Malatesta, Barbara Costa, Silvia Marracci, Irma Nardi, Claudia Martini, Characterization of a cloned Xenopus laevis Serotonin 5-HT1A receptor expressed in the NIH-3T3 cell line, Molecular Brain Research, 1999, 63, 2, 380

    CrossRef

  10. 10
    Marie-Bernadette Assié, Cristina Cosi, Wouter Koek, Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity, European Journal of Pharmacology, 1999, 386, 1, 97

    CrossRef

  11. 11
    B Gardner, P G. Strange, Agonist action at D2(long) dopamine receptors: ligand binding and functional assays, British Journal of Pharmacology, 1998, 124, 5
  12. 12
    David A. Hall, Philip G. Strange, Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors, British Journal of Pharmacology, 1997, 121, 4
  13. 13
    Chantevy Pou, Emmanuel K. Nénonéné, Tomás A. Reader, Annick Fargin, The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue, General Pharmacology: The Vascular System, 1997, 29, 5, 737

    CrossRef